Dr. Lamont J. Barlow
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Columbia University College of Physicians and Surgeons (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 130
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: Columbia University College of Physicians and Surgeons
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
NY license 287083
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- NYU Langone Hospitals New York, NY
Medical groups
- New York University (6,134 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 130
- Services billed
- 534
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Automated urinalysis test | 76 | 66 |
| Ultrasound measurement of bladder capacity after voiding | 64 | 58 |
| Established patient office or other outpatient visit, 30-39 minutes | 45 | 41 |
| New patient office or other outpatient visit, 45-59 minutes | 31 | 31 |
| Established patient office or other outpatient visit, 20-29 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in New York, NY | 452 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in New York, NY | 278 |
| Myrbetriq (mirabegron) Other prescribers in New York, NY | 207 |
| Finasteride Other prescribers in New York, NY | 94 |
| Dutasteride Other prescribers in New York, NY | 47 |
| Estradiol Other prescribers in New York, NY | 26 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in New York, NY | 24 |
| Trospium Chloride Other prescribers in New York, NY | 20 |
| Fesoterodine Fumarate Er (fesoterodine fumarate) Other prescribers in New York, NY | 17 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in New York, NY | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $198 in total to this clinician.
| Coloplast Corp | $198 |
|---|
| Food and Beverage | $198 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $52,931 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Bacillus Calmette- Guerin BCG in Participants with High-risk Non-muscle Invasiv…
Merck Sharp & Dohme LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.